Market Capitalization

Three of the world's most famous ETFs are being rebranded. We explore the strategy behind adding 'State Street' and what it means for investors.

ResourceTec Corp. appoints two mining industry titans to its board, a bold move to attract capital for its ambitious projects despite having no funds.

Blackbaud's latest accelerator cohort goes beyond code, backing diverse founders and AI-driven tools to redefine efficiency and impact in the nonprofit sector.

Nukkleus Inc. completes its acquisition of Star 26 Capital, pivoting to defense tech and aiming to fix critical supply chain issues amid market volatility.

Citigroup reaffirms shareholder returns with a $0.60 common stock dividend, signaling confidence as it navigates a massive corporate restructuring.

The biotech firm faces a delisting threat after its equity turned negative. Can recent funding save its Nasdaq spot and its ambitious drug pipeline?

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

VisionWave Holdings launches a major joint venture with Israeli partner AIPHEX, integrating AI, quantum tech, and a key financial contract.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.

The Chinese auto-tech firm regained Nasdaq's minimum bid price but still faces delisting over its low market value, setting up a critical hearing.

A new report reveals a paradoxical trend: plaintiff firms are filing fewer securities lawsuits but securing record-breaking, multi-million dollar settlements.

Eason Technology is betting its future on Chinese real estate with a deal that could dilute shareholders by over 80%. But can it get past the NYSE?

The Golden Globes partners with prediction market Polymarket in a bold bid for relevance, but the high-stakes deal brings new scrutiny and ethical questions.

Indonesia Energy Corp. starts pre-drilling for two new wells in Sumatra, a key move in its growth strategy and a boost for national energy security.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

Sanuwave Health posts record revenue, defying industry-wide turmoil as reimbursement cuts reshape the advanced wound care market. How did they do it?

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.

With its radical solar car on the line, Aptera appoints a VW and BMW veteran as Chairman. Can traditional auto expertise finally launch a new era of efficiency?

With its Q4 earnings approaching, all eyes are on Federal Realty to see if its premium retail strategy can sustain its record dividend amid market shifts.